Sanda Tin

935 total citations
15 papers, 716 citations indexed

About

Sanda Tin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sanda Tin has authored 15 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sanda Tin's work include Cancer Cells and Metastasis (10 papers), Metastasis and carcinoma case studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sanda Tin is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Metastasis and carcinoma case studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sanda Tin collaborates with scholars based in United States, Slovakia and Italy. Sanda Tin's co-authors include Evan N. Cohen, James M. Reuben, Naoto T. Ueno, Wendy A. Woodward, Antonio Giordano, Massimo Cristofanilli, Simone Anfossi, Michal Mego, Vicente Valero and Ricardo H. Álvarez and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Sanda Tin

15 papers receiving 712 citations

Peers

Sanda Tin
Wen Liu China
Sanda Tin
Citations per year, relative to Sanda Tin Sanda Tin (= 1×) peers Wen Liu

Countries citing papers authored by Sanda Tin

Since Specialization
Citations

This map shows the geographic impact of Sanda Tin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanda Tin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanda Tin more than expected).

Fields of papers citing papers by Sanda Tin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanda Tin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanda Tin. The network helps show where Sanda Tin may publish in the future.

Co-authorship network of co-authors of Sanda Tin

This figure shows the co-authorship network connecting the top 25 collaborators of Sanda Tin. A scholar is included among the top collaborators of Sanda Tin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanda Tin. Sanda Tin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Cohen, Evan N., Tamer M. Fouad, Bang‐Ning Lee, et al.. (2019). Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer. Breast Cancer Research and Treatment. 176(3). 545–556. 23 indexed citations
3.
Rahal, Omar, Adam R. Wolfe, Pijus K. Mandal, et al.. (2017). Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(4). 1034–1043. 128 indexed citations
4.
Mego, Michal, Hui Gao, Evan N. Cohen, et al.. (2016). Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer. Oncotarget. 8(22). 35656–35668. 48 indexed citations
5.
Cohen, Evan N., Hui Gao, Simone Anfossi, et al.. (2015). Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. PLoS ONE. 10(7). e0132710–e0132710. 90 indexed citations
6.
Mego, Michal, Hui Gao, Evan N. Cohen, et al.. (2015). Abstract P4-01-04: Circulating tumor cells (CTC) are associated with defects in innate and adaptive immunity in inflammatory breast cancer (IBC) patients. Cancer Research. 75(9_Supplement). P4–1. 1 indexed citations
7.
Mego, Michal, Zhuang Zuo, Hui Gao, et al.. (2014). Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thrombosis and Haemostasis. 113(3). 593–598. 33 indexed citations
9.
Giordano, Antonio, Hui Gao, Evan N. Cohen, et al.. (2013). Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Annals of Oncology. 24(10). 2515–2521. 27 indexed citations
10.
11.
Giordano, Antonio, Hui Gao, Simone Anfossi, et al.. (2012). Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer. Molecular Cancer Therapeutics. 11(11). 2526–2534. 172 indexed citations
12.
Yennurajalingam, Sriram, Jie Willey, J. Lynn Palmer, et al.. (2012). The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study. Journal of Palliative Medicine. 15(10). 1059–1064. 52 indexed citations
13.
Cohen, Evan N., Hui Gao, Eleni Andreopoulou, et al.. (2009). Soluble Factors and Circulating Tumor Cells in Inflammatory Breast Cancer.. Cancer Research. 69(24_Supplement). 2135–2135. 1 indexed citations
14.
Mego, Michal, Sendurai A. Mani, Sanda Tin, et al.. (2009). Circulating Tumor Cells (CTCs) and Epithelial Mesenchymal Transition (EMT) in Breast Cancer: Describing the Heterogeneity of Microscopic Disease.. Cancer Research. 69(24_Supplement). 3011–3011. 8 indexed citations
15.
Gao, Hui, Alessandra Ferrajoli, Evan N. Cohen, et al.. (2008). Treatment with Lenalidomide Has a Positive Immunomodulatory Effect in Patients with Chronic Lymphocytic Leukemia.. Blood. 112(11). 2107–2107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026